{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:35:14Z","timestamp":1791099314783,"version":"4.1.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.pnpbp.2011.12.010","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T03:02:52Z","timestamp":1325300572000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase"],"prefix":"10.1016","volume":"38","author":[{"given":"Zden\u011bk","family":"Fi\u0161ar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.12.010_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","article-title":"The effects of cannabinoids on the brain","volume":"58","author":"Ameri","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0010","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0015","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.85.13.4934","article-title":"cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties","volume":"85","author":"Bach","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.pnpbp.2011.12.010_bb0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2174\/138161209788168029","article-title":"Endocannabinoids in the treatment of mood disorders: evidence from animal models","volume":"15","author":"Bambico","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0006-2952(75)90368-8","article-title":"Effect of \u03949-tetrahydrocannabinol on monoamine oxidase activity of rat tissues in vivo","volume":"24","author":"Banerjee","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0041-008X(77)90106-5","article-title":"Action of \u03949-tetrahydrocannabinol on membrane-bound monoamine oxidase activity","volume":"40","author":"Banerji","year":"1977","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2011.12.010_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(95)00487-4","article-title":"Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides","volume":"287","author":"Barg","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11064-005-2746-5","article-title":"Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain","volume":"30","author":"Bazinet","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00008877-200509000-00003","article-title":"Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders","volume":"16","author":"Beardsley","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0055","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1471-4159.2002.01263.x","article-title":"Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine","volume":"83","author":"Ben-Shachar","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0060","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1523\/JNEUROSCI.0442-05.2005","article-title":"Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types","volume":"25","author":"Bodor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0065","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"59","author":"Bolla","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.02.013","article-title":"Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities","volume":"80","author":"Bosier","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.pnpbp.2011.12.010_bb0075","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of \u03949-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1471-4159.2005.03074.x","article-title":"In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to \u03949-tetrahydrocannabinol","volume":"93","author":"Butovsky","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-2952(76)90335-X","article-title":"Effect of cannabis extract on the uterine monoamine oxidase activity of normal and estradiol treated rats","volume":"25","author":"Chakrabarty","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.4152-06.2007","article-title":"Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation","volume":"27","author":"Cheer","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.neuro.29.051605.112834","article-title":"Endocannabinoid-mediated synaptic plasticity in the CNS","volume":"29","author":"Chevaleyre","year":"2006","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","article-title":"Synaptic plasticity: multiple forms, functions, and mechanisms","volume":"33","author":"Citri","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0115","first-page":"471","article-title":"Acute and chronic effects of tetrahydrocannabinols on monoamide oxidase activity: possible vehicle\/tetrahydrocannabinol interactions","volume":"17","author":"Clarke","year":"1977","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007691-199312000-00013","article-title":"Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage","volume":"15","author":"Cone","year":"1993","journal-title":"Ther Drug Monit"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.12.010_bb0125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/187152709789824615","article-title":"Signal transduction via cannabinoid receptors","volume":"8","author":"Dalton","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/jm00079a016","article-title":"Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor","volume":"35","author":"D'Ambra","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11920-002-0026-5","article-title":"Cannabis and psychosis","volume":"4","author":"Degenhardt","year":"2002","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/070674370605100903","article-title":"Is cannabis use a contributory cause of psychosis?","volume":"51","author":"Degenhardt","year":"2006","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.12.010_bb0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0155","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"Di Marzo","year":"2005","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2008.02.015","article-title":"Training-induced structural changes in the adult human brain","volume":"192","author":"Draganski","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0074-7742(06)78010-2","article-title":"Cannabinoids and psychosis","volume":"78","author":"D'Souza","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0175","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.mp.4001016","article-title":"Synaptic plasticity and mood disorders","volume":"7","author":"Duman","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.31887\/DCNS.2009.11.3\/rsduman","article-title":"Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression","volume":"11","author":"Duman","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"issue":"12","key":"10.1016\/j.pnpbp.2011.12.010_bb0185","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0195","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/bi900413g","article-title":"Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases","volume":"48","author":"Edmondson","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","article-title":"Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system","volume":"56","author":"Emrich","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2011.12.010_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0210","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/0006-2952(86)90285-6","article-title":"Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors","volume":"35","author":"Fagervall","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0215","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1530-0277.1994.tb00090.x","article-title":"Platelet monoamine oxidase activity in alcoholics, alcoholics with drug dependence, and cocaine addicts","volume":"18","author":"Faraj","year":"1994","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-5793(96)00891-5","article-title":"Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat","volume":"393","author":"Felder","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archpsyc.60.10.1033","article-title":"Early reactions to cannabis predict later dependence","volume":"60","author":"Fergusson","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874473710902010051","article-title":"Phytocannabinoids and endocannabinoids","volume":"2","author":"Fi\u0161ar","year":"2009","journal-title":"Curr Drug Abuse Rev"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0235","first-page":"5","article-title":"Cannabinoids and atherosclerosis","volume":"110","author":"Fi\u0161ar","year":"2009","journal-title":"Prague Med Rep"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.12.010_bb0240","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","article-title":"Inhibition of monoamine oxidase activity by cannabinoids","volume":"381","author":"Fi\u0161ar","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2011.12.010_bb0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14712\/fb2010056040135","article-title":"Intracellular signalling pathways and mood disorders","volume":"56","author":"Fi\u0161ar","year":"2010","journal-title":"Folia Biol"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0250","first-page":"17","article-title":"Depression, antidepressants, and peripheral blood components","volume":"29","author":"Fi\u0161ar","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0255","first-page":"51","article-title":"Imipramine distribution among red blood cells, plasma and brain tissue","volume":"15","author":"Fi\u0161ar","year":"1996","journal-title":"Gen Physiol Biophys"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0260","first-page":"307","article-title":"Distribution of antidepressants between plasma and red blood cells","volume":"27","author":"Fi\u0161ar","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"issue":"5","key":"10.1016\/j.pnpbp.2011.12.010_bb0265","first-page":"645","article-title":"Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers","volume":"31","author":"Fi\u0161ar","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0270","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1021\/bi602455n","article-title":"Monotopic enzymes and lipid bilayers: a comparative study","volume":"46","author":"Fowler","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0275","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.12.010_bb0280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.mp.4001628","article-title":"Active zones for presynaptic plasticity in the brain","volume":"10","author":"Garc\u00eda-Junco-Clemente","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0285","first-page":"482","article-title":"Effect of \u03949-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro","volume":"22","author":"Gawienowski","year":"1982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0290","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2007.07.030","article-title":"Neurobiology of addiction. An integrative review","volume":"75","author":"Goodman","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0295","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neubiorev.2008.03.004","article-title":"Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders","volume":"32","author":"Gorzalka","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0300","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1355617703950016","article-title":"Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study","volume":"9","author":"Grant","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0305","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/cbdv.200790151","article-title":"The toxicology of cannabis and cannabis prohibition","volume":"4","author":"Grotenhermen","year":"2007","journal-title":"Chem Biodivers"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2011.12.010_bb0310","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1007\/BF02246225","article-title":"Biochemistry and pharmacology of moclobemide, a prototype RIMA","volume":"106","author":"Haefely","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0315","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","article-title":"Adverse effects of cannabis","volume":"352","author":"Hall","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0320","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1460-9568.2007.05476.x","article-title":"Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission","volume":"25","author":"Haller","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0325","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.0953-816x.2001.01536.x","article-title":"Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity","volume":"13","author":"Hampson","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-002-1210-3","article-title":"Nefazodone decreases anxiety during marijuana withdrawal in humans","volume":"165","author":"Haney","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0335","first-page":"1","article-title":"The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine","volume":"26","author":"Hasan","year":"1988","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0340","first-page":"351","article-title":"The effect of in vivo treatment with (\u2212) delta 1-tetrahydrocannabinol, and other psychoactive drugs on the in vitro uptake of biogenic amines","volume":"22\u201323","author":"Hershkowitz","year":"1978","journal-title":"Adv Biosci"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.12.010_bb0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0350","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1461145705005651","article-title":"Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment","volume":"9","author":"Hill","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0360","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"Hill","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0365","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-3084(00)00191-2","article-title":"The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes","volume":"108","author":"Hillard","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0370","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1468-1331.2006.01547.x","article-title":"Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease","volume":"13","author":"Horstink","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0375","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2011.12.010_bb0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.12.010_bb0385","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-1819.2010.02178.x","article-title":"Connectivity between mitochondrial functions and psychiatric disorders","volume":"65","author":"Hroudov\u00e1","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0390","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","article-title":"Neural mechanisms of addiction: the role of reward-related learning and memory","volume":"29","author":"Hyman","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0395","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"Iversen","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0400","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.mp.4001920","article-title":"Serotonergic vulnerability and depression: assumptions, experimental evidence and implications","volume":"12","author":"Jans","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0405","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects","volume":"115","author":"Jiang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0410","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","article-title":"Psychiatric effects of cannabis","volume":"178","author":"Johns","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200721010-00001","article-title":"Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications","volume":"21","author":"Kato","year":"2007","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ceca.2007.11.005","article-title":"Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder","volume":"44","author":"Kato","year":"2008","journal-title":"Cell Calcium"},{"issue":"3 Pt 1","key":"10.1016\/j.pnpbp.2011.12.010_bb0425","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","article-title":"Mitochondrial dysfunction in bipolar disorder","volume":"2","author":"Kato","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0430","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9378(99)70583-1","article-title":"Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta","volume":"181","author":"Kenney","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0435","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/mol.105.016428","article-title":"Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity","volume":"69","author":"Kim","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2011.12.010_bb0440","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-009-1591-7","article-title":"The endocannabinoid system as a target for modelling psychosis","volume":"206","author":"Koethe","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0445","series-title":"Neurobiology of addiction","first-page":"289","author":"Koob","year":"2006"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0450","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm058183t","article-title":"The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications","volume":"48","author":"Lambert","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0455","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00018-006-6027-5","article-title":"The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction","volume":"63","author":"Laviolette","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.12.010_bb0460","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1369-1600.2008.00106.x","article-title":"Cannabis and psychiatric disorders: it is not only addiction","volume":"13","author":"Leweke","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0465","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0470","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0475","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-3-540-74805-2_14","article-title":"Presynaptic modulation by endocannabinoids","volume":"184","author":"Lovinger","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0480","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-511X-1-4","article-title":"Quantification of anandamide content in animal cells and tissues: the normalization makes the difference","volume":"1","author":"Maccarrone","year":"2002","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0485","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0490","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(04)16200-4","article-title":"Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies","volume":"363","author":"Macleod","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0495","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(06)68468-7","article-title":"Does cannabis use cause schizophrenia?","volume":"367","author":"Macleod","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0500","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(07)61651-1","article-title":"Cannabis and psychosis","volume":"370","author":"Macleod","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-0102(01)00241-3","article-title":"Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals","volume":"40","author":"Maejima","year":"2001","journal-title":"Neurosci Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0510","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0515","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tips.2005.10.005","article-title":"Antidepressant action: to the nucleus and beyond","volume":"26","author":"Malberg","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0520","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.phrs.2007.09.003","article-title":"Enhancement of endocannabinoid signaling and the pharmacotherapy of depression","volume":"56","author":"Mangieri","year":"2007","journal-title":"Pharmacol Res"},{"issue":"3 Suppl","key":"10.1016\/j.pnpbp.2011.12.010_bb0525","first-page":"27","article-title":"Neuromodulatory functions of the endocannabinoid system","volume":"29","author":"Marsicano","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0530","first-page":"15","article-title":"Effect of cannabinoids on the activity of monoamine oxidase in normal human platelets","volume":"90","author":"Mazor","year":"1982","journal-title":"Arch Int Physiol Biochim"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0535","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.conb.2009.05.008","article-title":"Presynaptic plasticity: targeted control of inhibitory networks","volume":"19","author":"McBain","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0540","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","article-title":"A total synthesis of dl-\u03941-tetrahydrocannabinol, the active constituent of hashish","volume":"87","author":"Mechoulam","year":"1965","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0550","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.01.002","article-title":"Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats","volume":"534","author":"Mendiguren","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0555","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","article-title":"Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles","volume":"24","author":"Mesulam","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0560","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","article-title":"Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression","volume":"63","author":"Meyer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2011.12.010_bb0565","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archgenpsychiatry.2009.156","article-title":"Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0570","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/BF00978372","article-title":"Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal \u03949-tetrahydrocannabinol treatments","volume":"18","author":"Molina-Holgado","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0575","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(96)00753-4","article-title":"Effect of maternal \u03949-tetrahydrocannabinol on developing serotonergic system","volume":"316","author":"Molina-Holgado","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0580","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0361-9230(96)00434-0","article-title":"Maternal exposure to \u03949-tetrahydrocannabinol (\u03949-THC) alters indolamine levels and turnover in adult male and female rat brain regions","volume":"43","author":"Molina-Holgado","year":"1997","journal-title":"Brain Res Bull"},{"issue":"5","key":"10.1016\/j.pnpbp.2011.12.010_bb0585","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00210-004-0921-x","article-title":"Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain","volume":"369","author":"Moranta","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0590","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ab.2007.09.030","article-title":"An optimized GC\u2013MS method detects nanomolar amounts of anandamide in mouse brain","volume":"373","author":"Muccioli","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0595","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jat\/29.8.842","article-title":"THC can be detected in brain while absent in blood","volume":"29","author":"Mura","year":"2005","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0600","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jps.20037","article-title":"Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans","volume":"93","author":"Naef","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0605","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0610","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuroscience.2005.01.026","article-title":"CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons","volume":"136","author":"Ny\u00edri","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0615","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuropharm.2005.04.014","article-title":"Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain","volume":"49","author":"Oliva","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0620","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157015911795017047","article-title":"Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders","volume":"9","author":"Onaivi","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0625","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0630","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1208\/aapsj070364","article-title":"The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids","volume":"7","author":"Pertwee","year":"2005","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.pnpbp.2011.12.010_bb0635","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB\u2081 and CB\u2082","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0640","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0645","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","article-title":"Neuropsychological performance in long-term cannabis users","volume":"58","author":"Pope","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0650","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0376-8716(02)00334-4","article-title":"Early-onset cannabis use and cognitive deficits: what is the nature of the association?","volume":"69","author":"Pope","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2011.12.010_bb0655","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2005.05.014","article-title":"WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT3 receptor function","volume":"517","author":"Przegali\u0144ski","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0660","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1389557033405287","article-title":"Monoamine oxidases: to inhibit or not to inhibit","volume":"3","author":"Ramsay","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0665","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0670","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0006-2952(01)00616-5","article-title":"Cannabinoid-induced alterations in brain disposition of drugs of abuse","volume":"61","author":"Reid","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0675","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0161-813X(03)00106-2","article-title":"Monoamine oxidase-B inhibition in Alzheimer's disease","volume":"25","author":"Riederer","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0680","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.npp.1301330","article-title":"Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats","volume":"32","author":"Rubino","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2011.12.010_bb0685","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0690","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00210-005-0026-1","article-title":"Chronic \u03949-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex","volume":"372","author":"Sagredo","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0695","doi-asserted-by":"crossref","first-page":"L298","DOI":"10.1152\/ajplung.00157.2002","article-title":"Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics","volume":"284","author":"Sarafian","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0700","doi-asserted-by":"crossref","first-page":"L1202","DOI":"10.1152\/ajplung.00371.2005","article-title":"Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo","volume":"290","author":"Sarafian","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0705","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0306-3623(84)90104-6","article-title":"Cannabis extract, but not \u03941-tetrahydrocannabinol, inhibits human brain and liver monoamine oxidase","volume":"15","author":"Schurr","year":"1984","journal-title":"Gen Pharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0710","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mi.11.1.6","article-title":"Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?","volume":"11","author":"Seely","year":"2011","journal-title":"Mol Interv"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2011.12.010_bb0715","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-009-1660-y","article-title":"Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB","volume":"213","author":"Selvaraj","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0720","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874473710801010081","article-title":"The chronic effects of cannabis on memory in humans: a review","volume":"1","author":"Solowij","year":"2008","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0725","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1139\/jpn.0705","article-title":"Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?","volume":"32","author":"Solowij","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0730","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S1092852900016965","article-title":"Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0735","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2004.00806.x","article-title":"Early adolescent cannabis exposure and positive and negative dimensions of psychosis","volume":"99","author":"Stefanis","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0740","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuint.2003.08.009","article-title":"Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex-involvement of Na+\/K+-ATPase","volume":"44","author":"Steffens","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0745","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0750","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.mp.4001711","article-title":"Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research","volume":"10","author":"Stork","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0755","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0760","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","article-title":"Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data","volume":"169","author":"Tanda","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0765","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"issue":"Suppl 5","key":"10.1016\/j.pnpbp.2011.12.010_bb0770","first-page":"259S","article-title":"Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration","volume":"14","author":"Tasker","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.12.010_bb0775","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1469-7793.2000.00041.x","article-title":"Target-specific expression of pre- and postsynaptic mechanisms","volume":"525","author":"T\u00f3th","year":"2000","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.12.010_bb0780","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JME-08-0190","article-title":"Signal transduction of the CB1 cannabinoid receptor","volume":"44","author":"Turu","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0785","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jphs.FMJ04003X4","article-title":"New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia","volume":"96","author":"Ujike","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0790","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.12.010_bb0795","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0800","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1369-1600.2007.00065.x","article-title":"Effect of cannabinoids on platelet serotonin uptake","volume":"12","author":"Velenovsk\u00e1","year":"2007","journal-title":"Addict Biol"},{"issue":"52908","key":"10.1016\/j.pnpbp.2011.12.010_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/52908","article-title":"Endocannabinoid system and synaptic plasticity: implications for emotional responses","volume":"2007","author":"Viveros","year":"2007","journal-title":"Neural Plast"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0810","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/187153008785700082","article-title":"Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications","volume":"8","author":"Viveros","year":"2008","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2011.12.010_bb0815","first-page":"S287","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0820","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.010_bb0825","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study","volume":"325","author":"Zammit","year":"2002","journal-title":"BMJ"},{"issue":"27","key":"10.1016\/j.pnpbp.2011.12.010_bb0830","first-page":"464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \u201cspice gold\u201d","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch Arztebl Int"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:42:03Z","timestamp":1759520523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0278584611003757"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}